Autoantibodies and SLE: the threshold for disease

Area of Science:

• Immunology
• Autoimmunity
• Clinical Medicine

Background:

• Autoantibodies are increasingly detected in healthy individuals, not always indicating disease.
• Some autoantibodies play crucial roles in immune regulation, suggesting a healthy function.
• Distinguishing benign autoimmunity from preclinical disease remains a challenge.

Approach:

• Reviewing current findings on SLE-associated antibodies in healthy populations.
• Analyzing the potential roles of autoantibodies in immune homeostasis and disease development.
• Discussing implications for predicting disease transition and therapeutic strategies.

Key Points:

• The presence of autoantibodies in healthy individuals is common and may represent a normal immune response.
• Autoantibodies can have beneficial immune regulatory functions.
• Predicting the progression from preclinical autoimmunity to clinical autoimmune diseases like SLE is critical for early intervention.

Conclusions:

• Further research into the mechanisms governing autoantibody regulation is needed.
• Identifying biomarkers for disease transition could enable timely therapeutic interventions.
• Understanding benign autoimmunity offers insights into preventing or aborting autoimmune disease development.